Item 2.02 Results of Operations and Financial Condition. OnNovember 10, 2021 ,Tempest Therapeutics, Inc. (the "Company") issued a press release announcing its financial results for the third fiscal quarter endedSeptember 30, 2021 . A copy of the Company's press release datedNovember 10, 2021 , titled "Tempest Reports Third Quarter 2021 Financial Results and Provides Corporate Highlights" is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information (including the exhibit hereto) is being furnished under "Item 2.02 Results of Operations and Financial Condition" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release datedNovember 10, 2021 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source